| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 297,836 | 289,268 | 277,090 | 274,011 | | Cost of Revenue | 150,272 | 145,618 | 142,594 | 167,326 | | | Gross Profit | 147,564 | 143,650 | 134,496 | 106,685 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 54,312 | 53,047 | 50,731 | 60,423 | | Non Recurring | 3,760 | 1,403 | 721 | (767) | | Others | 9,959 | 9,660 | 8,844 | (25,288) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 79,533 | 79,540 | 74,200 | 72,317 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (487) | (871) | (635) | (1,303) | | Earnings Before Interest And Taxes | 79,046 | 78,669 | 73,565 | 71,014 | | Interest Expense | 9,262 | 8,200 | 8,099 | 8,219 | | Income Before Tax | 69,784 | 70,469 | 65,466 | 62,795 | | Income Tax Expense | 23,110 | 26,567 | 24,811 | 23,663 | | Minority Interest | (148) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 46,526 | 43,902 | 40,655 | 39,132 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 46,526 | 43,902 | 40,655 | 39,132 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $46,526 | $43,902 | $40,655 | $39,132 |
|
0.47% Nasdaq 0.00%
Income Statement
